Cell Symposia: Hallmarks of Cancer
October 29 - 31, 2012
Westin Market Street, San Francisco, CA, USA
Rene Bernards, The Netherlands Cancer Institute, The Netherlands
Elizabeth Blackburn, University of California San Francisco, USA
Peter Campbell, Sanger Institute, UK
Peter Carmeliet, VIB & Katholieke Universiteit Leuven, Belgium
Lynda Chin, MD Anderson Cancer Centre, USA
Lisa Coussens, Oregon Health & Science University, USA
John Dick, Ontario Cancer Institute/ Princess Margaret Hospital, Canada
Peter Friedl, Radboud University Nijmegen Medical Centre, The Netherlands
Richard Gilbertson, St. Jude Children’s Research Hospital, USA
William Hait, Johnson & Johnson, USA (panel discussion)
Douglas Hanahan (organizer), École Polytechnique Fédérale de Lausanne, Switzerland
Sandra Horning, Genentech, USA (panel discussion)
Peter Jones, University of Southern California, USA
Michael Karin, University of California San Diego, USA
Richard Marais, Paterson Institute for Cancer Research, UK
Matthew Meyerson, Harvard University, USA
Emannuelle Passegue, University of California San Francisco, USA
Neal Rosen, Memorial Sloan-Kettering Cancer Center, USA
Xiaodong Wang, National Institute of Biological Sciences, China
Valerie Weaver, University of California San Francisco, USA
Robert Weinberg (organizer), Whitehead Institute, USA
Douglas Hanahan, École Polytechnique Fédérale de Lausanne, Switzerland
Robert Kruger, Deputy Editor, Cell
Li-Kuo Su, Editor, Cancer Cell
Robert Weinberg, Whitehead Institute, USA
There has been tremendous progress in understanding key aspects of cancer, such as the impact of genomic instability, the unique mechanisms that cancer cells use to sustain their growth, and the role of stromal cells in promoting tumor growth and dissemination. This improved knowledge has led to the development of many new cancer therapeutics, several of which are already in clinical use. The aim of the Hallmarks of Cancer Symposium is to highlight recent exciting advances by bringing together key leaders in the field and to facilitate the translation of basic research discoveries into improvements in cancer treatment.
Session topics will include:
- cancer genomics/genomic instability
- cancer stem cells/ tumor-initiating cells
- abnormal growth, metabolism, and apoptosis
- the tumor microenvironment
- metastasis
